Skip to main content

CITIGROUP INC

Position in GH — Guardant Health, Inc.

CIK 831001 NEW YORK, NY

Position in GH

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$18,204,339
+$2,125,309 QoQ
Shares Held
121,338
-30.3% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#122
of 593 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$3,780,756
PutShares
25,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $1,355,830,348 across 36 Diagnostics & Research names. GH ranks #16 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GH

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,780,756 25,200
2026-06-30 $18,204,339 121,338
2026-03-31 $16,079,030 174,072
2025-12-31 $19,293,019 188,888
2025-09-30 $1,200,489 19,214
2025-06-30 $4,345,078 83,495
2025-03-31 $4,076,180 95,685
2024-12-31 $3,152,850 103,203
2024-09-30 $2,629,864 114,641
2024-06-30 $903,249 31,276
2024-03-31 $797,203 38,643
2024-03-31 $3,044,988 147,600
2024-03-31 $1,763,865 85,500
2023-12-31 $890,322 32,914
2023-09-30 $492,171 16,605
2023-06-30 $2,051,553 57,306
2023-03-31 $2,391,277 102,017
2022-12-31 $476,979 17,536
2022-12-31 $1,904,000 70,000
2022-09-30 $1,488,235 27,647
2022-09-30 $6,454,217 119,900
2022-06-30 $1,251,869 31,033
2022-06-30 $2,593,862 64,300
2022-03-31 $2,300,910 34,736
2021-12-31 $7,466,389 74,649
2021-09-30 $4,513,609 36,106
2021-06-30 $10,145,699 81,695
2021-03-31 $10,753,427 70,445
2020-12-31 $9,001,750 69,846
2020-09-30 $7,744,339 69,282
2020-06-30 $6,184,133 76,225
2020-03-31 $5,010,642 71,992